Section Review: Oncologic, Endocrine & Metabolic: Platinum agents in the treatment of cancer
- 1 June 1996
- journal article
- Published by Informa Healthcare in Expert Opinion on Investigational Drugs
- Vol. 5 (6) , 681-693
- https://doi.org/10.1517/13543784.5.6.681
Abstract
No abstract availableKeywords
This publication has 22 references indexed in Scilit:
- High-dose carboplatin and etoposide for salvage chemotherapy of germ cell tumoursEuropean Journal Of Cancer, 1995
- A Phase II Trial of High-Dose Mitoxantrone, Carboplatin, and Cyclophosphamide with Autologous Bone Marrow Rescue for Recurrent Epithelial Ovarian Carcinoma: Analysis of Risk Factors for Clinical OutcomeGynecologic Oncology, 1995
- Salvage therapy of germ cell tumoursBritish Journal of Cancer, 1995
- Preclinical toxicology and tissue platinum distribution of novel oral antitumour platinum complexes: ammine/amine platinum(IV) dicarboxylatesCancer Chemotherapy and Pharmacology, 1994
- New platinum antitumor complexesPublished by Elsevier ,1993
- In vitro platinum drug chemosensitivity of human cervical squamous cell carcinoma cell lines with intrinsic and acquired resistance to cisplatinBritish Journal of Cancer, 1993
- Lack of nephrotoxicity of oral ammine/amine platinum (IV) dicarboxylate complexes in rodentsBritish Journal of Cancer, 1993
- A randomized study comparing cisplatin or carboplatin with etoposide in patients with advanced non-small-cell lung cancer: European Organization for Research and Treatment of Cancer Protocol 07861.Journal of Clinical Oncology, 1990
- The duke afm program intensive induction chemotherapy for metastatic breast cancerCancer, 1990
- Promotion of microtubule assembly in vitro by taxolNature, 1979